Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib with Stupp Regimen in Newly Diagnosed Glioblastoma
NCT04119674Phase 2Completed
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Mar 2019
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib in glioblastoma (GBM), sponsored by Zhejiang Cancer Hospital. Started Mar 2019; status: completed.
02
Drugs
anlotinib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT04119674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04119674.